Translational Medicine and Therapeutics -- Research Starter Grants

Funding Agency:
Pharmaceutical Research and Manufacturers of America Foundation

“Translational medicine and therapeutics is a discipline focused on bridging experimental and computational technologies and discoveries in the research laboratory to their application in clinical practice. Examples of research components include activities in molecular and cellular biology, pathophysiology, systems biology, bioinformatics, modeling and simulation, and other quantitative sciences to connect basic biological concepts and entities to directly address unmet medical needs. The goals are to use clinical observation as the basis for hypothesis generation to further basic research and to efficiently advance the product of basic research to patients.”

The Translational Medicine and Therapeutics program aims to promote development and use of experimental and computational methods in an integrative approach toward clinical needs in diagnosis, treatment, and prevention. This can involve enhanced understanding of human biological and disease processes, but requires a strong translational component. The program will support the concepts of translational medicine and therapeutics as defined by the Foundation and requires collaboration between basic and clinical research.

Deadline: Feb. 1, 2021.

Agency Website

Areas of Interest

Translational Medicine and Therapeutics awards will advance training and support career development of scientists engaged in research that significantly addresses specific clinical problems and integrates innovative technologies with advanced biological, chemical, and pharmacological sciences and engineering methodologies in areas such as

  • Genetics (Molecular, Pharmaco-, Population, Medical)
  • Genomics (Functional, Structural, Toxico-, Pharmaco-, Comparative)
  • Systems (Biology and Pharmacology)
  • Pathways and Networks
  • Integrative Biology
  • Modeling and Simulation
Target Identification and Validation
  • Biomarker Discovery and Validation
  • Vaccine Development
  • Molecular Epidemiology
  • Imaging
  • Disease Modeling

Emphasis is placed on the identification and specification of unmet clinical needs and development of new experimental and computational approaches and technologies that facilitate translation of research into an elucidation and understanding of normal processes of human biology, as they function in disease.

Eligibility Requirements

  • Those holding the academic rank of Assistant Professor (or Research Assistant Professor) within a tenure track (or Research track) appointment, or Instructor, if eligible to apply for independent research funding by their institution, are eligible to apply for these research starter grants, providing their proposed research is neither directly nor indirectly already being subsidized to any significant degree by an extramural support mechanism. Individuals receiving only intramural funding or start-up funding from their institution are eligible to apply for RSG awards
  • Applicants will be judged on the scientific merits of the proposed research, and on the degree of need and fit within the scope and goals of the program.
  • The program is not intended for those in postdoctoral training programs. However, those enrolled in postdoctoral training programs scheduled to conclude by July 1, 2021, who will hold an academic appointment by that time, may apply.
  • Applicants must be sponsored by the department or unit in which the proposed research is to be undertaken.
  • Applications must be submitted in conjunction with an accredited U.S. university or research institution
  • All applicants must be U.S. citizens or permanent residents by the time of initiation of the grant.
  •  If support for the proposed research is obtained otherwise after the application has been submitted, the Foundation must be so informed.
  •  These funds are not transferable.



Amount Description

The program provides a research grant of $100,000 for one year.

Funding Type



Junior Faculty


Engineering and Physical Sciences
Medical - Clinical Science
Medical - Translational

External Deadline

February 1, 2021